5122 Drugs, drug proprietaries, and druggist sundries

Introduction

• What it is: This MCC is designated for retail businesses that sell pharmaceutical products and related items.
• Risk level: Medium — Due to the sensitive nature of health-related products, there's increased scrutiny.
• Acceptance difficulty: Medium — While commonly accepted, some processors may require additional documentation.
• Typical business models: pharmacies; drug stores; health supplement retailers; e-commerce sites selling medications.
• For merchants: Expect moderate merchant discount rates (MDR); potential for reserve requirements; thorough vetting during onboarding.
• What PSPs expect: Business license; proof of product sources; compliance with healthcare regulations if applicable.

Payment Insights & Benchmarks

Merchants in this MCC should plan for higher payment friction compared to standard e-commerce. Acceptance often depends on method mix, fraud controls, and PSP risk appetite.

Payment methods

Cards: often subjected to strict regulations, leading to higher decline rates.

• E-wallets: useful for discreet transactions, though acceptance varies by provider.
• Bank transfers: reliable for larger transactions but may involve longer processing times.
• Vouchers and prepaid cards: preferred for customer privacy and chargeback mitigation.
• Crypto: gaining traction, but acceptance is limited and fluctuates with regulatory changes.

Authentication & security

Strong customer authentication (3DS, SCA) is frequently mandated by payment processors.

• These measures help curb unauthorized transactions, although they can lead to increased false declines.
• Continuous fraud monitoring should include transaction patterns and customer behavior.

Benchmarks (indicative, not guaranteed)

MDR: generally higher than standard e-commerce rates due to perceived risk.

• Rolling reserves: may be implemented to manage risk, often at higher percentages.
• Settlement cycles: expected to be longer (typically 7+ days).
• Chargeback ratios: typically elevated compared to retail averages, particularly for digital products.
• Card approval rates: usually lower; alternative payments like e-wallets may see better success rates.

Key metrics to monitor

Decline rates segmented by payment method and transaction type.

• Chargeback ratios and reasons analyzed between fraud and service-related claims.
• Customer acquisition costs versus average transaction values.
• Authorization success rates across various providers and geographies.

Risk & Compliance

Merchants operating under MCC 5122 face significant scrutiny due to the high-risk nature of their products and exposure to potential legal and regulatory challenges. PSPs and acquirers implement stringent measures, requiring merchants to be proactive in managing chargebacks, fraud, and robust AML/KYC compliance.

Chargebacks & fraud

High incidence of friendly fraud, where customers claim they didn't authorize transactions for legitimate purchases, leading to disputes.

• Use of stolen credit cards and returns of goods purchased fraudulently can be prevalent.
• Common mitigation tools include velocity checks to limit transaction frequency, behavioral analytics to detect abnormal patterns, and device fingerprinting to identify repeat offenders.

AML/KYC expectations

Strict identity verification processes must be in place, including government-issued ID checks and sanctions screenings.

• Merchants are expected to conduct source-of-funds verification, particularly for large transactions or any suspicious activity.
• Manual review triggers include substantial cash deposits, patterns of frequent, high-value transactions, and the use of VPNs or proxies that mask user identity.

Operational red flags

Lack of transparency regarding ownership and operators of the merchant site raises significant concerns among PSPs/acquirers.

• Marketing activities that target high-risk geographic areas or rely on unverified affiliate networks can signal potential compliance failure.
• Absence of clear and accessible drug-related product information, including health warnings or usage guidelines, reflects negatively on operational practices.
• Inadequate handling of product returns or exchanges can lead to increased chargebacks and customer dissatisfaction.

Onboarding Checklist

Merchants operating under this MCC should prepare a comprehensive onboarding package prior to engaging with PSPs or acquirers. A thoroughly compiled submission is crucial for enhancing approval chances and expediting the review process.

Legal & corporate documents

company registration and incorporation documents

• disclosure of beneficial owners (UBO) and corporate structure
• valid licenses for the distribution of pharmaceuticals and related products
• policies: Terms of Service, Privacy, AML/KYC, Refund Policy

Financials & risk management

recent financial statements and cashflow forecasts

• liquidity or reserve model for product returns and refunds
• description of antifraud setup tailored for the pharmaceutical sector

Product & marketing

demo access or screenshots of the live platform

• marketing plan and traffic source overview (affiliates, online ads, etc.)
• geographic targeting information specific to pharmaceutical products
• KYC flow details relevant to customer purchases

Technical integration & security

payment architecture overview with supported methods/providers

• description of compliance with SCA/3DS protocols, if applicable
• PCI DSS compliance status and data storage policy

Operations

customer support coverage (languages, operating hours)

• SLA for handling disputes and product returns
• limits on orders or subscriptions according to regulatory guidelines
• internal process for managing product recalls and customer notifications

Regulation & Licensing

Licensing and certification are essential for merchants in this MCC, as regulatory bodies enforce compliance to ensure safety and legality in the sale of pharmaceuticals and related products. Recognition of licenses by PSPs may vary based on the merchant's jurisdiction and the specific markets they serve.

Operator licenses

Food and Drug Administration (FDA) — critical in the United States for any entity handling pharmaceuticals or controlled substances.

• Health Canada — regulates drug products and ensuring safety in the Canadian market.
• European Medicines Agency (EMA) — necessary for drug approval and marketing within the EU.
• State pharmacy boards — individual states within the US issue licenses for pharmacy operation, and recognition can vary significantly.
• Some countries require additional local pharmacy licenses for the sale of specific drug categories.

Geo-restrictions

Sales of controlled substances are heavily regulated, with outright bans in certain jurisdictions.

• In the US, pharmaceuticals are treated differently on a state-by-state basis, making local licensing essential.
• Some regions may ban online sales of certain drug products, affecting e-commerce capabilities.

Certifications & audits

Good Manufacturing Practice (GMP) certification for compliance in drug production.

• Licensing audits to ensure adherence to health and safety regulations.
• Regular inspections by regulatory authorities to verify compliance with local laws.
• Quality management system certifications like ISO 9001 for operational excellence.

Official Definitions & Network Comparisons

This section shows how major card networks define this MCC and highlights practical differences that affect merchant onboarding.

Explanation:

While the definitions across networks are similar, variations in terminology and emphasis, such as "pharmaceuticals" vs. "drugs," can impact the onboarding process. Each network may have unique requirements based on regional regulations or specific product categorizations. Common denial reasons can include non-compliance with local laws, incomplete licensing, or restrictions on selling specific drugs or substances.

Alternative MCC Codes

Merchants often confuse this MCC with other categories. The table below shows which codes are related, why they are confused, and what risks misclassification brings.

Rule of thumb for merchants:

Ensure you categorize your business accurately. If your products are primarily pharmaceuticals or drug-related, use MCC 5122. Misclassifying can lead to compliance issues and may result in account termination. Always align your MCC with the primary nature of your retail offerings.

Best Practices for Merchants

Merchants under the MCC 5122, which includes drugs, drug proprietaries, and druggist sundries, must navigate strict compliance and risk management practices. The following best practices will help mitigate fraud risks, improve payment acceptance, and develop strong relations with payment service providers (PSPs).

Classification & transparency

always use the correct MCC; misclassification can lead to account termination

• provide clear information about the nature of products sold, including any licensing requirements
• ensure transparent business practices and display all terms and conditions visibly

Fraud & chargeback reduction

implement 3DS or step-up authentication especially for high-value transactions

• use clear and descriptive billing descriptors to minimize confusion for customers
• maintain thorough event logs for transactions to support evidence in chargeback disputes

Payment acceptance optimization

offer multiple payment methods (e.g., credit cards, digital wallets) to reduce cart abandonment

• analyze transaction patterns and optimize routing based on geographic insights for faster approvals
• consider using distinct merchant IDs (MIDs) for different product lines or regions to better manage risks

Operational discipline

monitor key performance indicators (KPIs) such as transaction success rates, chargeback ratios, and customer complaints

• conduct regular compliance audits to ensure adherence to industry regulations and internal standards
• designate a specific team or individual for dispute management to streamline responses and issue resolution

Payouts & liquidity

establish liquidity buffers to accommodate rolling reserves and prevent cash flow interruptions

• automate anti-money laundering (AML) checks to verify withdrawals, particularly for larger sums
• regularly review payout processes and monitor for any irregular withdrawal activities

Business Scope & Examples

This MCC encompasses businesses involved in the retail sale of pharmaceutical drugs, drug proprietaries, and sundry items typically found in drugstores. Merchants classified under this category generally provide over-the-counter and prescription medications, along with related health and wellness products.

Models

retail pharmacies and drugstores

• online pharmacies selling prescription and OTC medications
• health and wellness stores offering supplements and personal care products
• specialty pharmacies providing specific medications (e.g., oncology drugs)
• compounding pharmacies creating customized medications

Borderline cases

Cosmetic stores — shops selling beauty products may confuse classification but usually do not focus on health-related pharmacology.

• Health food stores — while they sell supplements, they may not operate as drugstores and therefore differ in classification.

Signals for correct classification

business sells prescription medications requiring a pharmacist's oversight

• a significant portion of inventory consists of OTC healthcare products
• transactions often involve health insurance reimbursement processes